PMID- 18022570 OWN - NLM STAT- MEDLINE DCOM- 20080108 LR - 20111117 IS - 1083-8791 (Print) IS - 1083-8791 (Linking) VI - 13 IP - 12 DP - 2007 Dec TI - HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation. PG - 1417-21 AB - Cytomegalovirus (CMV) infection is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT); however, we have little information on the clinical association of various human leukocyte antigen (HLA) alleles with CMV infection. We reviewed medical records of 60 patients who underwent allo-HSCT. The effect of the 7 most frequent HLA alleles on the incidence of CMV infection and disease was analyzed, including HLA-A*02, A*11, A*24, B*13, B*40(60), DRB1*15, and DRB1*09. All the patients were monitored for CMV infection at least once weekly within 3 months. CMV infection was found in 38 (63.3%) patients on a median of day 36 (range: 16-89). Diagnosis of CMV disease was established in 6 (10.0%) patients, comprising pneumonia (n = 2), enterocolitis (n = 2), and hemorrhagic cystitis (n = 2). CMV disease was successfully treated using ganciclovir or foscarnet combined with immune globulins in 4 patients. The other 2 patients died without improvement of CMV disease. In multivariate analysis, grade II-IV acute graft-versus-host disease (aGVHD), CMV seronegative donors, and HLA-DRB1*09 were associated with increased incidence of CMV infection and disease after allo-HSCT. We suggest that more cautions should be taken to prevent CMV infection in patients with HLA-DRB1*09 after allo-HSCT. FAU - Du, Jinwei AU - Du J AD - Department of Hematology, Peking University First Hospital, Beijing, People's Republic of China. FAU - Liu, Jing AU - Liu J FAU - Gu, Jiangying AU - Gu J FAU - Zhu, Ping AU - Zhu P LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Biol Blood Marrow Transplant JT - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation JID - 9600628 RN - 0 (HLA-DR Antigens) RN - 0 (HLA-DRB1 Chains) SB - IM MH - Adolescent MH - Adult MH - Child MH - Child, Preschool MH - Cytomegalovirus Infections/epidemiology/*immunology MH - Female MH - *Genetic Predisposition to Disease MH - Graft vs Host Disease/complications/virology MH - HLA-DR Antigens/*immunology MH - HLA-DRB1 Chains MH - Hematopoietic Stem Cell Transplantation/*adverse effects MH - Humans MH - Incidence MH - Infant MH - Infant, Newborn MH - Male MH - Middle Aged MH - Retrospective Studies MH - Risk Factors MH - Transplantation, Homologous/adverse effects EDAT- 2007/11/21 09:00 MHDA- 2008/01/09 09:00 CRDT- 2007/11/21 09:00 PHST- 2007/07/16 00:00 [received] PHST- 2007/09/07 00:00 [accepted] PHST- 2007/11/21 09:00 [pubmed] PHST- 2008/01/09 09:00 [medline] PHST- 2007/11/21 09:00 [entrez] AID - S1083-8791(07)00451-X [pii] AID - 10.1016/j.bbmt.2007.09.003 [doi] PST - ppublish SO - Biol Blood Marrow Transplant. 2007 Dec;13(12):1417-21. doi: 10.1016/j.bbmt.2007.09.003.